BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 19636203)

  • 1. Non-functioning adrenal incidentalomas are associated with elevated D-dimer levels.
    Yener S; Comlekci A; Akinci B; Secil M; Demir T; Ertilav S; Yesil S
    J Endocrinol Invest; 2009 Apr; 32(4):338-43. PubMed ID: 19636203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carotid intima media thickness is increased and associated with morning cortisol in subjects with non-functioning adrenal incidentaloma.
    Yener S; Genc S; Akinci B; Secil M; Demir T; Comlekci A; Ertilav S; Yesil S
    Endocrine; 2009 Jun; 35(3):365-70. PubMed ID: 19277910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Traditional and novel cardiovascular risk factors in non-functioning adrenal adenomas.
    Yener S; Cömlekci A; Yuksel F; Sevinc A; Ertilav S; Yesil S
    Eur J Intern Med; 2012 Jan; 23(1):83-7. PubMed ID: 22153537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated post-dexamethasone suppression cortisol concentrations correlate with hormonal alterations of the hypothalamo-pituitary adrenal axis in patients with adrenal incidentalomas.
    Tsagarakis S; Roboti C; Kokkoris P; Vasiliou V; Alevizaki C; Thalassinos N
    Clin Endocrinol (Oxf); 1998 Aug; 49(2):165-71. PubMed ID: 9828902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cortisol secretion from adrenal adenomas discovered as incidentalomas is responsive to ACTH.
    Olsen H; Olofsson L; Mjöman M
    Clin Endocrinol (Oxf); 2014 Mar; 80(3):335-41. PubMed ID: 23865937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adrenal incidentaloma: an overview of hormonal data from the National Italian Study Group.
    Mantero F; Masini AM; Opocher G; Giovagnetti M; Arnaldi G
    Horm Res; 1997; 47(4-6):284-9. PubMed ID: 9167966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subclinical Cushing's syndrome in patients with adrenal incidentaloma: clinical and biochemical features.
    Rossi R; Tauchmanova L; Luciano A; Di Martino M; Battista C; Del Viscovo L; Nuzzo V; Lombardi G
    J Clin Endocrinol Metab; 2000 Apr; 85(4):1440-8. PubMed ID: 10770179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low DHEAS: A Sensitive and Specific Test for the Detection of Subclinical Hypercortisolism in Adrenal Incidentalomas.
    Dennedy MC; Annamalai AK; Prankerd-Smith O; Freeman N; Vengopal K; Graggaber J; Koulouri O; Powlson AS; Shaw A; Halsall DJ; Gurnell M
    J Clin Endocrinol Metab; 2017 Mar; 102(3):786-792. PubMed ID: 27797672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Saliva versus serum cortisol to identify subclinical hypercortisolism in adrenal incidentalomas: simplicity versus accuracy.
    Vieira-Correa M; Giorgi RB; Oliveira KC; Hayashi LF; Costa-Barbosa FA; Kater CE
    J Endocrinol Invest; 2019 Dec; 42(12):1435-1442. PubMed ID: 31456173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiometabolic profile of non-functioning and autonomous cortisol-secreting adrenal incidentalomas. Is the cardiometabolic risk similar or are there differences?
    Araujo-Castro M; Robles Lázaro C; Parra Ramírez P; Cuesta Hernández M; Sampedro Núñez MA; Marazuela M
    Endocrine; 2019 Dec; 66(3):650-659. PubMed ID: 31473918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patients with apparently nonfunctioning adrenal incidentalomas may be at increased cardiovascular risk due to excessive cortisol secretion.
    Androulakis II; Kaltsas GA; Kollias GE; Markou AC; Gouli AK; Thomas DA; Alexandraki KI; Papamichael CM; Hadjidakis DJ; Piaditis GP
    J Clin Endocrinol Metab; 2014 Aug; 99(8):2754-62. PubMed ID: 24712565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is there an association between non-functioning adrenal adenoma and endothelial dysfunction?
    Yener S; Baris M; Secil M; Akinci B; Comlekci A; Yesil S
    J Endocrinol Invest; 2011 Apr; 34(4):265-70. PubMed ID: 20530985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Limited Role of Hair Cortisol and Cortisone Measurement for Detecting Cortisol Autonomy in Patients With Adrenal Incidentalomas.
    Puglisi S; Leporati M; Amante E; Parisi A; Pia AR; Berchialla P; Terzolo M; Vincenti M; Reimondo G
    Front Endocrinol (Lausanne); 2022; 13():833514. PubMed ID: 35222288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Luteinizing hormone and insulin resistance in menopausal patients with adrenal incidentalomas: The cause-effect relationship?
    Marina LV; Ivović M; Tančić-Gajić M; Arizanović Z; Raković D; Milin-Lazović J; Kendereški A; Micić D; Vujović S
    Clin Endocrinol (Oxf); 2018 Apr; 88(4):541-548. PubMed ID: 29288564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subclinical Cushing's syndrome in adrenal incidentaloma.
    Terzolo M; Osella G; Alì A; Borretta G; Cesario F; Paccotti P; Angeli A
    Clin Endocrinol (Oxf); 1998 Jan; 48(1):89-97. PubMed ID: 9509073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is the 1mg-dexamethasone suppression test a precise marker of glucocorticoid excess and cardiometabolic risk in patients with adrenal incidentalomas?
    Araujo-Castro M; Hanzu FA; Pascual-Corrales E; García Cano AM; Marchan M; Escobar-Morreale HF; Valderrabano P; Casals G
    Endocrine; 2023 Oct; 82(1):161-170. PubMed ID: 37351760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant adrenal sensitivity to multiple ligands in unilateral incidentaloma with subclinical autonomous cortisol hypersecretion: a prospective clinical study.
    Reznik Y; Lefebvre H; Rohmer V; Charbonnel B; Tabarin A; Rodien P; Lecomte P; Bardet S; Coffin C; Mahoudeau J;
    Clin Endocrinol (Oxf); 2004 Sep; 61(3):311-9. PubMed ID: 15355446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study of glucose tolerance in consecutive patients harbouring incidental adrenal tumours. Study Group of Incidental Adrenal Adenoma.
    Fernández-Real JM; Engel WR; Simó R; Salinas I; Webb SM
    Clin Endocrinol (Oxf); 1998 Jul; 49(1):53-61. PubMed ID: 9797847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The association between adrenal adenoma size, autonomous cortisol secretion and metabolic derangements.
    Bleier J; Pickovsky J; Apter S; Fishman B; Dotan Z; Tirosh A; Shlomai G
    Clin Endocrinol (Oxf); 2022 Mar; 96(3):311-318. PubMed ID: 34877671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical features, risk of mass enlargement, and development of endocrine hyperfunction in patients with adrenal incidentalomas: a long-term follow-up study.
    Falcetta P; Orsolini F; Benelli E; Agretti P; Vitti P; Di Cosmo C; Tonacchera M
    Endocrine; 2021 Jan; 71(1):178-188. PubMed ID: 32915435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.